These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


501 related items for PubMed ID: 32705169

  • 1. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X, Wu S, Zhang J, Li M, Xu F, Wang A, Lei Y, Zhu G.
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y, He Y, Lv S, Hou X, Li L, Song J.
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [Abstract] [Full Text] [Related]

  • 3. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.
    Wang Q, Zhang L, Cui Y, Zhang C, Chen H, Gu J, Qian J, Luo C.
    Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408
    [Abstract] [Full Text] [Related]

  • 4. Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
    Oppermann H, Faust H, Yamanishi U, Meixensberger J, Gaunitz F.
    PLoS One; 2019 Jan; 14(6):e0218972. PubMed ID: 31247000
    [Abstract] [Full Text] [Related]

  • 5. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
    Kalhori MR, Irani S, Soleimani M, Arefian E, Kouhkan F.
    J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
    [Abstract] [Full Text] [Related]

  • 6. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L, Liu J, Zhong Z, Gong X, Liu W, Shi L, Li X.
    Brain Res; 2016 Sep 01; 1646():441-450. PubMed ID: 27328425
    [Abstract] [Full Text] [Related]

  • 7. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
    Ni H, Wang K, Xie P, Zuo J, Liu W, Liu C.
    Cell Mol Neurobiol; 2021 Jan 01; 41(1):79-90. PubMed ID: 32236901
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W, Ding X, Ye H, Wang J, Shao J, Huang T.
    Neuroreport; 2018 Dec 12; 29(18):1578-1585. PubMed ID: 30371540
    [Abstract] [Full Text] [Related]

  • 9. Bisphenol S (BPS) induces glioblastoma progression via regulation of EZH2-mediated PI3K/AKT/mTOR pathway in U87-MG cells.
    Ko MY, Park H, Kim Y, Min E, Cha SW, Lee BS, Hyun SA, Ka M.
    Toxicology; 2024 Sep 12; 507():153898. PubMed ID: 39032682
    [Abstract] [Full Text] [Related]

  • 10. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S, Urisman A, Oses-Prieto JA, Arnott D, Burlingame AL.
    Mol Cell Proteomics; 2017 Jan 12; 16(1):39-56. PubMed ID: 27834733
    [Abstract] [Full Text] [Related]

  • 11. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y, Xie P.
    J Biochem Mol Toxicol; 2019 Nov 12; 33(11):e22392. PubMed ID: 31503386
    [Abstract] [Full Text] [Related]

  • 12. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J, Zhang XY, Sun DK, Tian LQ, Xu P.
    Eur Rev Med Pharmacol Sci; 2019 Apr 12; 23(8):3447-3454. PubMed ID: 31081099
    [Abstract] [Full Text] [Related]

  • 13. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ, Xu WR, Chen B, Wang YY, Yang N, Wang LJ, Zhang YL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 12; 23(19):8321-8331. PubMed ID: 31646562
    [Abstract] [Full Text] [Related]

  • 14. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H, Ji D, Huang Z, Li J.
    Arch Biochem Biophys; 2020 Nov 30; 695():108628. PubMed ID: 33049294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
    Zhang A, Peng S, Sun S, Ye S, Zhao Y, Wu Q.
    Cancer Med; 2024 Aug 30; 13(16):e70100. PubMed ID: 39149873
    [Abstract] [Full Text] [Related]

  • 19. Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Dong J, Qian Y, Zhang W, Xu J, Wang L, Fan Z, Jia M, Wei L, Yang H, Luo X, Wang Y, Jiang Y, Huang Z, Wang Y.
    Eur J Pharmacol; 2024 Apr 05; 968():176401. PubMed ID: 38331340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.